patient view
This page is a research summary built from public sources (FDA, NIH, clinical trial registries). It is not medical advice.Always talk to your doctor about treatment decisions. Drug information here may be incomplete or out of date — verify with your prescriber and the manufacturer's package insert.
drug · unknown
prabotulinumtoxin A
Phase 2updated 2mo agoby $AEON AEON Biopharma, Inc.🔗 ChEMBL
Phase 2community read0 votes
Unknown drug with a maximum clinical stage of Approval (across all indications), with an approval for skin aging and 2 investigational indications.
targets
Synaptosomal-associated protein 25
all catalysts(0)
nothing on the calendar yet
News(0)
no news has mentioned this drug yet
comments(0)
5-min edit window · permanent after that